معرفی
Clinical Professor Stewart Kellie is affiliated with the University of Sydney and works at the Children's Hospital, Westmead. His primary role is in paediatric oncology and haematology, focusing on clinical research and treatment protocols for childhood cancers. His research spans medulloblastoma risk stratification, germ cell tumours, and biomarkers in tumour diagnosis.
Publications emphasize molecular diagnostics, therapeutic advancements in paediatric cancers, and clinical trial outcomes. Recent work addresses low-level BCR::ABL1 transcripts in childhood leukemias and BRAF-mediated brain tumours. He collaborates internationally on protocols like the SJMB03 medulloblastoma trial.
No scientific awards are explicitly listed, though his contributions to high-impact journals suggest recognition in paediatric oncology. His clinical roles involve managing complex cases such as pineoblastoma and subcutaneous panniculitis-like lymphoma. Research extends to imaging applications (e.g., FDG PET-CT for Langerhans cell histiocytosis) and prognostic biomarkers like neutrophil-lymphocyte ratios.
His work bridges clinical practice and translational research, addressing both therapeutic efficacy and global health equity in childhood cancer care.
